Tick-Borne Encephalitis in Kazakhstan: A case report

2020

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.14744/etd.2019.70431
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Tick-borne encephalitis (TBE) exists over a wide geographical area worldwide. In here, a clinical case with TBE was presented. A 34 years old man complained of weakness, high fever with chills, body aches, headache, malaise. He was hospitalized in the Infectious Diseases clinic. He gave a history of the visit to an endemic area of TBE. Laboratory examination showed leukocytosis, neutrophilosis and ESR acceleration. Upon the clinical diagnosis of 'Fever of unknown origin' levofloxacin and metronidazole, ceftazidime were started. On the third day of treatment, neurological symptoms of encephalitis developed. The patient was transferred to the intensive care unit. ELISA test for TBE virus IgM was positive. Cerebrospinal fluid (CSF) revealed serous meningitis. TBE was diagnosed. Treatment with human immunoglobulin TBE, glucocorticoid, and diuretics were administered. The outcome of the disease was favorable. The physicians should be aware about the clinical presentations of TBE in endemic areas.